- Home
- LPCN vs COHN Comparison
LPCN vs COHN Comparison
Compare LPCN & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- COHN
- Stock Information
- Founded
- LPCN 1997
- COHN 1999
- Country
- LPCN United States
- COHN United States
- Employees
- LPCN N/A
- COHN N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- COHN Investment Bankers/Brokers/Service
- Sector
- LPCN Health Care
- COHN Finance
- Exchange
- LPCN Nasdaq
- COHN Nasdaq
- Market Cap
- LPCN 16.4M
- COHN 17.8M
- IPO Year
- LPCN N/A
- COHN N/A
- Fundamental
- Price
- LPCN $3.24
- COHN $8.10
- Analyst Decision
- LPCN Strong Buy
- COHN
- Analyst Count
- LPCN 1
- COHN 0
- Target Price
- LPCN $10.00
- COHN N/A
- AVG Volume (30 Days)
- LPCN 10.5K
- COHN 8.4K
- Earning Date
- LPCN 03-13-2025
- COHN 03-10-2025
- Dividend Yield
- LPCN N/A
- COHN 12.33%
- EPS Growth
- LPCN N/A
- COHN N/A
- EPS
- LPCN N/A
- COHN N/A
- Revenue
- LPCN $11,198,144.00
- COHN $73,777,000.00
- Revenue This Year
- LPCN N/A
- COHN N/A
- Revenue Next Year
- LPCN $37.31
- COHN N/A
- P/E Ratio
- LPCN N/A
- COHN N/A
- Revenue Growth
- LPCN N/A
- COHN N/A
- 52 Week Low
- LPCN $2.91
- COHN $6.10
- 52 Week High
- LPCN $11.79
- COHN $12.82
- Technical
- Relative Strength Index (RSI)
- LPCN 41.52
- COHN 37.72
- Support Level
- LPCN $3.00
- COHN $8.01
- Resistance Level
- LPCN $3.57
- COHN $8.49
- Average True Range (ATR)
- LPCN 0.24
- COHN 0.42
- MACD
- LPCN -0.00
- COHN -0.02
- Stochastic Oscillator
- LPCN 23.29
- COHN 25.64
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About COHN Cohen & Company Inc.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.